Client’s specialty product had a complicated oral therapy regimen requiring supplemental support to patients.
Therapy administered for chronic life-threatening condition in which patients are generally older and polypharmic.
We built a team of Clinical Educators with strong therapeutic backgrounds to engage and stratify patients into high, medium, and low risk adherence categories based on their own answers in a non-adherence risk assessment typing tool.
Provided insight-driven ongoing patient and caregiver support through multichannel communication cadence based on non-adherence risk segment.
Closed the loop with the healthcare professional on feedback from patients and Clinical Educators.
Patients in the program receiving personalized Clinical Educator support on average stayed on the product for 2.5 more cycles (2.5 months) than patients not enrolled in the adherence support program.
The probability of patients in the program to refill their next prescription was 92% versus 63% probability for those not enrolled in the adherence support program.
Enrolled Patients |
Non-Enrolled Patients |
|
|
92% |
63% |
2.5 |
CASE STUDY (GLOBAL) Operationalized a global vaccine contact center in 12 weeks engaging with 800 HCPs and patients per day across 50 countries.
Read moreCASE STUDY (US) Integrated a contract Patient Diagnosis Liaison team (10+) into existing landscape of 50+ PDLs.
Read moreCASE STUDY (UK) Clinical Sales Specialist team recruited within 6 weeks to assist with launch of key respiratory brand into a competitive market.
Read more